Role of primary care in opioid prescribing for older head and neck cancer survivors
Cancer · 15.11.2024 · 130 (22) · 3913-3925
DOI: 10.1002/cncr.35478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 27.07.2024. Verfasst von Talya Salz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Head and Neck Neoplasms, Primary Health Care, Cancer Survivors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Older head and neck cancer (HNC) survivors have concerning rates of potentially unsafe opioid prescribing. Identifying the specialties of opioid prescribers for HNC survivors is critical for targeting the settings for opioid safety interventions. This study hypothesized that oncology and surgery providers are primarily responsible for opioid prescriptions in the year after treatment but that primary care providers (PCPs) are increasingly involved in prescribing over time.
Methods
Using linked Surveillance, Epidemiology, and End Results–Medicare data, a retrospective analysis was conducted of adults aged >65 years diagnosed between 2014 and 2017 with stage I–III HNC and who had ≥6 months of treatment‐free follow‐up through 2019. Starting at treatment completion, opioid fills were assigned to a prescriber specialty: oncology, surgery, primary care, pain management, or other. Prescriber patterns were summarized for each year of follow‐up. Multinomial logistic regression models captured the likelihood of opioids being prescribed by each specialty.
Results
Among 5135 HNC survivors, 2547 (50%) had ≥1 opioid fill (median, 2.1‐year follow‐up). PCPs prescribed 47% of all fills (42%–55% each year). PCPs prescribed opioids to 45% of survivors with ≥1 opioid fill, which was a greater share than other specialties. PCPs prescribed longer supplies of opioids (median, 20 days/fill; median, 30 days/year) than oncologists or surgeons. The likelihood of an opioid being prescribed by an oncology provider was four times lower than that of it being prescribed by a PCP.
Conclusions
PCP involvement in opioid prescribing remains high throughout HNC survivorship. Interventions to improve the safety of opioid prescribing should target primary care, as is typical for opioid reduction efforts in the noncancer population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- University of California Berkeley, Berkeley, California, USA.
- University of California San Diego School of Medicine, San Diego, California, USA.
- Mount Sinai Hospital, New York, New York, USA.
ORCID-Profile: Talya Salz, Natalie Moryl, Allison Lipitz-Snyderman
Förderung
- NCI NIH HHS
Zitieren
APA
Salz, T., Meza, A. M., Bradshaw, P. T., Jinna, S., Moryl, N., Kriplani, A., R Tringale, K., Flory, J., Korenstein, D., & Lipitz-Snyderman, A. (2024). Role of primary care in opioid prescribing for older head and neck cancer survivors. Cancer, 130(22), 3913-3925. https://doi.org/10.1002/cncr.35478
Vancouver
Salz T, Meza AM, Bradshaw PT, Jinna S, Moryl N, Kriplani A, et al. Role of primary care in opioid prescribing for older head and neck cancer survivors. Cancer. 2024;130(22):3913-3925. doi:10.1002/cncr.35478
BibTeX
@article{Salz2024,
author = {Salz, Talya and Meza, Akriti Mishra and Bradshaw, Patrick T and Jinna, Sankeerth and Moryl, Natalie and Kriplani, Anuja and R Tringale, Kathryn and Flory, James and Korenstein, Deborah and Lipitz-Snyderman, Allison},
title = {Role of primary care in opioid prescribing for older head and neck cancer survivors},
journal = {Cancer},
year = {2024},
volume = {130},
number = {22},
pages = {3913--3925},
doi = {10.1002/cncr.35478}
}
EUVIMED